Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash		$ 4
Restricted cash	224	1,000
Prepaid expenses	588	1,105
Total current assets	812	2,109
Investment in Virion	90	3,392
TOTAL ASSETS	902	5,501
CURRENT LIABILITIES:
Accounts payable and accrued expenses	15,899	16,185
Short-term loans, net of issuance costs	16,300	12,118
SPA Warrant	1,089	764
Total current liabilities	33,889	30,012
NON-CURRENT LIABILITIES
Fixed maturity consideration	5,573	4,123
Backstop put option liability	59,056	58,523
Virion contribution liability		3,605
Total liabilities	98,518	96,264
STOCKHOLDERS’ DEFICIT:
Common stock, $0.0001 par value; 300,000,000 shares authorized as of December 31, 2024 and 2023, respectively, 34,868,628 and 34,649,046 shares issued and outstanding as of December 31, 2024 and 2023, respectively.
Additional paid-in capital	107,919	105,292
Accumulated deficit	(205,535)	(196,055)
Total stockholders’ deficit	(97,616)	(90,763)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	902	5,501
Related Party [Member]
CURRENT LIABILITIES:
Accrued expenses-related party	$ 601	$ 946